ARTICLE | Company News

Zyomyx and CAT to develop antibody biochip

December 4, 2000 8:00 AM UTC

Zyomyx (Hayward, Calif.) and Cambridge Antibody (LSE:CAT) will jointly develop high-density protein biochips based on antibody arrays to detect proteins from complex biological mixtures. CAT will supply human antibody fragments using its phage display libraries, and Zyomyx will provide protein biochip systems technology. ...